Recombinant cardiac myosin fragment induces experimental autoimmune myocarditis via activation of Th1 and Th17 immunity

Autoimmunity

Volumn 41, Issue 6, 2008, Pages 490-499

  Daniels, Melvin D ^a   Hyland, Kenneth V ^a   Wang, Kegiang ^a   Engman, David M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Autoimmunity; Epitope spreading; Myocarditis; Th immunity

Indexed keywords

CARDIAC MYOSIN; GAMMA INTERFERON; IMMUNOGLOBULIN G1; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 6; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CELL INFILTRATION; CELL PROLIFERATION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HELPER CELL; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOPATHOGENESIS; IN VITRO STUDY; MALE; MONONUCLEAR CELL; MOUSE; MYOCARDITIS; NONHUMAN; SPLEEN CELL; TH1 CELL; TH17 CELL;

ANIMALS; AUTOIMMUNE DISEASES; CARDIAC MYOSINS; CELLS, CULTURED; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-4; INTERLEUKIN-6; MALE; MICE; MYOCARDITIS; RECOMBINANT PROTEINS; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS;

EID: 51849136575     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930802167902     Document Type: Article

References (43)

1. Pisani, B., Taylor, DO and Mason, JW (1997) Inflammatory myocardial diseases and cardiomyopathies. Am J Med, 102, pp. 459-469.
2. Caforio, AL and McKenna, WJ (1996) Recognition and optimum management of myocarditis. Drugs, 52, pp. 515-525.
3. Feldman, AM and McNamara, D. (2000) Myocarditis. N Engl J Med, 343, pp. 1388-1398.
4. Anandasabapathy, S. and Frishman, WH (1998) Innovative drug treatments for viral and autoimmune myocarditis. J Clin Pharmacol, 38, pp. 295-308.
5. Latif, N., Baker, CS, Dunn, MJ, Rose, ML, Brady, P. and Yacoub, MH (1993) Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. J Am Coll Cardiol, 22, pp. 1378-1384.
6. Konstadoulakis, MM, Kroumbouzou, H., Tsiamis, E., Trikas, A. and Toutouzas, P. (1993) Clinical significance of antibodies against tropomyosin, actin and myosin in patients with dilated cardiomyopathy. J Clin Lab Immunol, 40, pp. 61-67.
7. Goldman, JH, Keeling, PJ, Warraich, RS, Baig, MK, Redwood, SR, Dalla Libera, L, Sanderson, JE, Caforio, AL and McKenna, WJ (1995) Autoimmunity to alpha myosin in a subset of patients with idiopathic dilated cardiomyopathy. Br Heart J, 74, pp. 598-603.
8. Maisch, B., Maisch, S. and Kochsiek, K. (1982) Immune reactions in tuberculous and chronic constrictive pericarditis. Am J Cardiol, 50, pp. 1007-1013.
9. Aberer, E., Brunner, C., Suchanek, G., Klade, H., Barbour, A., Stanek, G. and Lassmann, H. (1989) Molecular mimicry and Lyme borreliosis: A shared antigenic determinant between Borrelia burgdorferi and human tissue. Ann Neurol, 26, pp. 732-737.
10. Kaplan, MH and Frengley, JD (1969) Autoimmunity to the heart in cardiac disease. Current concepts of the relation of autoimmunity to rheumatic fever, postcardiotomy and postinfarction syndromes and cardiomyopathies. Am J Cardiol, 24, pp. 459-473.
11. Cunha-Neto, E., Coelho, V., Guilherme, L., Fiorelli, A., Stolf, N. and Kalil, J. (1996) Autoimmunity in Chagas' disease: Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T-cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J Clin Invest, 98, pp. 1709-1712.
12. Neumann, DA, Burek, CL, Baughman, KL, Rose, NR and Herskowitz, A. (1990) Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol, 16, pp. 839-846.
13. Guilherme, L., Cunha-Neto, E., Coelho, V., Snitcowsky, R., Pomerantzeff, PM, Assis, RV, Pedra, F., Neumann, J., Goldberg, A., Patarroyo, ME, Pilleggi, F. and Kalil, J. (1995) Human heart-infiltrating t-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation, 92, pp. 415-420.
14. Cunha-Neto, E. and Kalil, J. (2001) Heart-infiltrating and peripheral T cells in the pathogenesis of human Chagas' disease cardiomyopathy. Autoimmunity, 34, pp. 187-192.
15. Neu, N., Rose, NR, Beisel, KW, Herskowitz, A., Gurri-Glass, G. and Craig, SW (1987) Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol, 139, pp. 3630-3636.
16. Pummerer, C., Berger, P., Fruhwirth, M., Ofner, C. and Neu, N. (1991) Cellular infiltrate, major histocompatibility antigen expression and immunopathogenic mechanisms in cardiac myosin-induced myocarditis. Lab Invest, 65, pp. 538-547.
17. Neu, N., Ploier, B. and Ofner, C. (1990) Cardiac myosin-induced myocarditis: Heart autoantibodies are not involved in the induction of the disease. J Immunol, 145, pp. 4094-4100.
18. Cunningham, MW (2001) Cardiac myosin and the Th1/Th2 paradigm in autoimmune myocarditis. Am J Pathol, 159, pp. 5-12.
19. Fuse, K., Kodama, M., Ito, M., Okura, Y., Kato, K., Hanawa, H., Aoki, S. and Aizawa, Y. (2003) Polarity of helper T-cell subsets represents disease nature and clinical course of experimental autoimmune myocarditis in rats. Clin Exp Immunol, 134, pp. 403-408.
20. Afanasyeva, M., Wang, Y., Kaya, Z., Stafford, EA, Dohmen, KM, Sadighi Akha, AA and Rose, NR (2001) Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation, 104, pp. 3145-3151.
21. Afanasyeva, M., Wang, Y., Kaya, Z., Park, S., Zilliox, MJ, Schofield, BH, Hill, SL and Rose, NR (2001) Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol, 159, pp. 193-203.
22. Smith, SC and Allen, PM (1991) Myosin-induced acute myocarditis is a T-cell-mediated disease. J Immunol, 147, pp. 2141-2147.
23. Rangachari, M., Mauermann, N., Marty, RR, Dirnhofer, S., Kurrer, MO, Komnenovic, V., Penninger, JM and Eriksson, U. (2006) T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med, 203, pp. 2009-2019.
24. Shiverick, KT, Thomas, LL and Alpert, NR (1975) Purification of cardiac myosin: Application to hypertrophied myocardium. Biochim Biophys Acta, 393, pp. 124-133.
25. Leon, JS, Daniels, MD, Toriello, KM, Wang, K. and Engman, DM (2004) A cardiac myosin-specific autoimmune response is induced by immunization with Trypanosoma cruzi proteins. Infect Immun, 72, pp. 3410-3417.
26. Leon, JS, Wang, K. and Engman, DM (2003) Captopril ameliorates myocarditis in acute experimental Chagas disease. Circulation, 107, pp. 2264-2269.
27. Leon, JS, Wang, K. and Engman, DM (2003) Myosin autoimmunity is not essential for cardiac inflammation in acute Chagas disease. J Immunol, 171, pp. 4271-4277.
28. Godsel, LM, Leon, JS, Wang, K., Fornek, JL, Molteni, A. and Engman, DM (2003) Captopril prevents experimental autoimmune myocarditis. J Immunol, 171, pp. 346-352.
29. Godsel, LM, Wang, K., Schodin, BA, Leon, JS, Miller, SD and Engman, DM (2001) Prevention of autoimmune myocarditis through the induction of antigen-specific peripheral immune tolerance. Circulation, 103, pp. 1709-1714.
30. Minoprio, P., el Cheikh, MC, Murphy, E., Hontebeyrie-Joskowicz, M., Coffman, R., Coutinho, A. and O'Garra, A. (1993) Xid-associated resistance to experimental Chagas' disease is IFN-gamma dependent. J Immunol, 151, pp. 4200-4208.
31. Donermeyer, DL, Beisel, KW, Allen, PM and Smith, SC (1995) Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart. J Exp Med, 182, pp. 1291-1300.
32. Vanderlugt, CL and Miller, SD (2002) Epitope spreading in immune-mediated diseases: Implications for immunotherapy. Nat Rev Immunol, 2, pp. 85-95.
33. Lawson, CM (2000) Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis. Cell Mol Life Sci, 57, pp. 552-560.
34. Fairweather, D., Kaya, Z., Shellam, GR, Lawson, CM and Rose, NR (2001) From infection to autoimmunity. J Autoimmun, 16, pp. 175-186.
35. Afanasyeva, M., Hill, SL, Kaya, Z., Rose, NR and Wang, Y. (2000) Characterization of murine autoimmune myocarditis induced by self and foreign cardiac myosin. J Am Coll Cardiol, 36, pp. 1992-1999.
36. Liao, L., Sindhwani, R., Rojkind, M., Factor, S., Leinwand, L. and Diamond, B. (1995) Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J Exp Med, 181, pp. 1123-1131.
37. Matsumoto, Y., Tsukada, Y., Miyakoshi, A., Sakuma, H. and Kohyama, K. (2004) C protein-induced myocarditis and subsequent dilated cardiomyopathy: Rescue from death and prevention of dilated cardiomyopathy by chemokine receptor DNA therapy. J Immunol, 173, pp. 3535-3541.
38. Vanderlugt, CL, Neville, KL, Nikcevich, KM, Eagar, TN, Bluestone, JA and Miller, SD (2000) Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. J Immunol, 164, pp. 670-678.
39. Maier, R., Miller, S., Kurrer, M., Krebs, P., de Giuli, R., Kremer, M., Scandella, E. and Ludewig, B. (2005) Quantification and characterization of myosin peptide-specific CD4+T cells in autoimmune myocarditis. J Immunol Methods, 304, pp. 117-125.
40. Rohn, TA, Jennings, GT, Hernandez, M., Grest, P., Beck, M., Zou, Y., Kopf, M. and Bachmann, MF (2006) Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur J Immunol, pp. 2857-2867.
41. Dal Canto, MC, Melvold, RW, Kim, BS and Miller, SD (1995) Two models of multiple sclerosis: Experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison. Microsc Res Tech, 32, pp. 215-229.
42. Ley, K., Smith, E. and Stark, MA (2006) IL-17a-producing neutrophil-regulatory T lymphocytes. Immunol Res, 34, pp. 229-242.
43. Cruz, A., Khader, SA, Torrado, E., Fraga, A., Pearl, JE, Pedrosa, J., Cooper, AM and Castro, AG (2006) Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol, 177, pp. 1416-1420.